Hybrid. Who knew a year ago this unremarkable word would have such a large part to play in pharma’s future lexicon and strategy building? Executives across the industry are working tirelessly to devise and execute a model in which pharma sales reps and other customer facing roles balance face-to-face (F2F), remote, and digital engagement.
Many questions remain unanswered; what is the right balance of F2F and remote engagement?
How do you create and maintain new relationships in the remote environment? How can we demonstrate what does – and doesn’t – and rapidly adapt and improve? Find out answers in this webinar Hybrid: Go-To-Market Models, Roles, and Capabilities for HCP Engagement.
Gain insight from this exclusive line-up of senior level executives:
- George Katzourakis, SVP, Head of Europe, GSK
- Cyril Schiever, SVP, President Mid-Europe Region, MSD
- Janneke van der Kamp, Head Region Europe, Novartis
- Brent Hooper, Partner, McKinsey
- Christina Hoffmann, Associate Partner, McKinsey
Join the discussion to learn how to combine F2F, remote, and digital engagement strategies.
Thanks to Matt Atkinson, Global Project Director, Reuters Events Pharma. If you have any questions, don’t hesitate to contact him at firstname.lastname@example.org
The Pharmaceutical Marketing Group